(Sr) Director, Medical Affairs - Oncology - Interventional Pulmonology

Job Description

LEADERSHIP OPPORTUNITY

\n

\n

Senior Director / Director, Medical Affairs

\n

\n

Galvanize Therapeutics · Oncology and Interventional Pulmonology

\n

\n

Company Overview

\n

\n

Galvanize Therapeutics is a commercial-stage biomedical platform company advancing therapeutic energy technologies designed to address important unmet needs. Its proprietary pulsed electric field platform supports differentiated solutions, including the Aliya® technology for soft-tissue ablation and oncology applications and the RheOx® technology for chronic bronchitis. With programs spanning oncology and pulmonary disease, Galvanize Therapeutics is building Medical Affairs capabilities to advance evidence generation, external scientific engagement, and education in oncology and interventional pulmonology.

\n

\n

Position Overview

\n

\n

Reports to: VP, Clinical and Medical Affairs

\n

\n

The Senior Director / Director, Medical Affairs will provide strategic and operational leadership for Medical Affairs programs supporting Galvanize Therapeutics' oncology assets and opportunities in interventional pulmonology. The role will lead external healthcare professional engagement, scientific insight gathering, evidence generation, data dissemination, scientific messaging, and education, while providing leadership to the Medical Science Liaison (MSL) and clinical case support groups.

\n

\n

This leader will build productive relationships with oncologists, interventional pulmonologists, thoracic surgeons, multidisciplinary tumor boards, and other key stakeholders. The role will also advance key opinion leader development through a focused investigator-initiated trial program designed to address evidence gaps and strengthen the company's oncology and interventional pulmonology portfolio.

\n

\n

Key Responsibilities

\n

\n

\n
• Collaborate closely with the VP, Clinical and Medical Affairs and the Chief Medical Officer (CMO) to develop and drive key Medical Affairs initiatives aligned with Galvanize Therapeutics' overall business strategy.
\n
• Ensure strong alignment across Clinical, Professional Education, Market Access, Commercial, Regulatory, Compliance, Legal, and Medical Affairs functions.
\n
• Lead scientific and clinical education for the MSL team, with emphasis on oncology, interventional pulmonology, and relevant external clinical research updates.
\n
• Develop and lead medical oncology, interventional pulmonology, and multidisciplinary tumor board engagement programs.
\n
• Support commercial program development aimed at institutionalizing the appropriate use of Galvanize Therapeutics products and technologies.
\n
• Lead publication planning and provide writing support and medical review for peer-reviewed manuscripts, meeting abstracts, presentations, posters, and other external scientific content.
\n
• Engage key opinion leaders and other experts in oncology and interventional pulmonology regarding abstract submissions, publications, scientific presentations, and investigator-initiated trials (IITs).
\n
• Oversee and participate in external engagement and insight gathering, in collaboration with commercial colleagues, to understand the current and future clinical role of Galvanize Therapeutics technologies in oncology and interventional pulmonology.
\n
• Lead the MSL and clinical case support groups, including team development, performance management, and strategic deployment.
\n
• Contribute to the development and execution of the strategic evidence plan and broader evidence-generation strategy.
\n
• Oversee, in partnership with Regulatory, Compliance, and Legal, the dissemination of scientific information on unapproved uses (SIUU) and the management of unsolicited off-label inquiries.
\n
• Serve as Chair of the Grants and Donations Committee and the IIT Committee.
\n
• Evaluate patterns in requests for off-label information or support to identify evidence gaps and areas of interest for potential expansion of use.
\n
• Prioritize and continue to develop a robust IIT program that addresses gaps in the oncology and interventional pulmonology portfolios while remaining consistent with business and evidence priorities.
\n
• Represent Galvanize Therapeutics to external partners and stakeholders, including regulatory agencies, industry collaborators, multidisciplinary tumor boards, healthcare professionals, customers, and the investment community.
\n
• Oversee analyses of internal clinical case-tracking dashboards and reports for data quality, adjudication, internal review, and insight generation, including monthly updates and slide-deck refreshes.
\n
• Provide medical review of clinical and commercial content intended for external dissemination, in collaboration with Compliance and Legal.
\n
• Collaborate cross-functionally to develop and maintain core scientific messaging for oncology, interventional pulmonology, and the company's broader technology portfolio.
\n
• Develop internal talent by creating opportunities for scientific, functional, technical, project, matrix, and people leadership that support current and future organizational needs.
\n
• Provide medical oversight and review of product complaints and related clinical trends.
\n

\n

\n

Qualifications

\n

\n

Education and Training

\n

\n

\n
• MD, DO, PharmD, PhD, or other relevant advanced scientific or clinical degree preferred.
\n

\n

\n

Skills and Experience

\n

\n

\n
• Minimum of 15 years of experience in the pharmaceutical, biotechnology, or medical device industry, or commensurate healthcare or research experience.
\n
• Substantial Medical Affairs leadership experience in oncology, with demonstrated expertise in interventional pulmonology or close collaboration with interventional pulmonologists strongly preferred.
\n
• Strong understanding of lung cancer care pathways, multidisciplinary thoracic oncology, bronchoscopy-based procedures, and the clinical workflow of interventional pulmonology preferred.
\n
• Existing relationships with oncology and/or interventional pulmonology key opinion leaders are highly desirable.
\n
• Experience commercializing medical devices, medical equipment, or other clinically complex healthcare technologies.
\n
• Previous responsibility and accountability across multiple indications, products, or clinical applications preferred.
\n
• Demonstrated ability to build and lead high-performing field medical and clinical support teams.
\n
• Experience with IITs, evidence-generation strategy, scientific communications, publications, grants, and compliant management of unsolicited off-label inquiries.
\n
• Effective leadership, interpersonal, presentation, writing, and communication skills.
\n
• Demonstrated ability to lead and influence internal and external stakeholders in a matrixed environment.
\n
• Proven ability to manage multiple priorities simultaneously and translate scientific and clinical insights into actionable strategy.
\n
• Ability to adapt quickly in a fast-paced, evolving company and operate with a high sense of urgency.
\n

\n

\n

Travel

\n

\n

Domestic travel is required to collaborate with internal and external partners, attend scientific and medical meetings, engage healthcare professionals, and support company programs as needed.